Liposomes are essentially a subtype of nanoparticles comprising a hydrophobic tail and a
hydrophilic head constituting a phospholipid membrane. The spherical or multilayered …

Liposomal drug delivery represents a highly adaptable therapeutic platform for treating a
wide range of diseases. Natural and synthetic lipids, as well as surfactants, are commonly …

Inflammation-associated diseases encompass a range of infectious diseases and non-
infectious inflammatory diseases, which continuously pose one of the most serious threats to …

Severe malaria is a medical emergency. It is a major cause of preventable childhood death
in tropical countries. Severe malaria justifies considerable global investment in malaria …

Pharmaceutical particle technology is employed to improve poor aqueous solubility of drug
compounds that limits in vivo bioavailability owing to their low dissolution rate in the …

Exosomes are described as nanoscale extracellular vesicles (EVs) secreted by multiple cell
types and extensively distributed in various biological fluids. They contain multifarious …

Over the past three decades, taxanes represent one of the most important new classes of
drugs approved in oncology. Paclitaxel (PTX), the prototype of this class, is an anti-cancer …

Combination strategy involving cyclodextrin (CD) complexation and liposomal system was
investigated for Paclitaxel (PTX) to improve loading. Complexation was done using 2, 6-di-O …

An improved PEGylated liposomal formulation of paclitaxel has been developed with the
purpose of improving the solubility of paclitaxel as well as the physicochemical stability of …

Lipid-based nanoparticles (LBNPs) are biocompatible and biodegradable vesicles that are
considered to be one of the most efficient drug delivery platforms. Due to the prominent …